Literature DB >> 6165766

Human lymphocytes can generate thymus-independent as well as thymus-dependent anti-hapten plaque-forming cell responses in vitro.

B Golding, S P Chang, H Golding, R E Jones, K L Pratt, D R Burger, M B Rittenberg.   

Abstract

Human lymphocytes from peripheral blood, tonsils, and adenoids produced hapten-specific anti-TNP antibodies after in vitro stimulation with TNP-Ba. This antigen did not appear to behave as a polyclonal activator since TNP-Ba-stimulated cells lysed TNP-conjugated sheep erythrocytes (SRBC) but not unconjugated SRBC or DPPC-conjugated SRBC, whereas cells from PWM-stimulated cultures formed hemolytic plaques with both haptenated and unhaptenated targets. In addition, TNP-Ba generated PFC were inhibitable by soluble hapten (TNP-EACA or TNP-BSA). B cells depleted of T cells (less than 1% E-RFC cells) were able to respond to TNP-Ba but not to PWM or TNP-KLH. When varying ratios of T and B cells were added to cultures the TNP-Ba anti-TNP response was found to have a linear correlation with the number of B cells added (r = 0.987) and was maximal in the absence of added T cells. This was in contrast to the response to TNP-KLH, which required T cells at a particular T:B ratio for optimal induction of anti-TNP PFC. Thus, both T-dependent and T-independent anti-hapten responses could be elicited in human lymphoid cell cultures.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165766

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines.

Authors:  J Goldstein; T Hoffman; C Frasch; E F Lizzio; P R Beining; D Hochstein; Y L Lee; R D Angus; B Golding
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

2.  Lipopolysaccharide from Brucella abortus behaves as a T-cell-independent type 1 carrier in murine antigen-specific antibody responses.

Authors:  M Betts; P Beining; M Brunswick; J Inman; R D Angus; T Hoffman; B Golding
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

3.  Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus.

Authors:  M B Zaitseva; H Golding; M Betts; A Yamauchi; E T Bloom; L E Butler; L Stevan; B Golding
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

4.  Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.

Authors:  B Golding; J Inman; P Highet; R Blackburn; J Manischewitz; N Blyveis; R D Angus; H Golding
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.